Biofrontera Inc. (BFRI) Earnings Call Transcripts
Biofrontera Inc.'s Latest Earnings Call - June 11, 2026
Biofrontera Inc. held its Annual Meeting of Stockholders on June 11, 2026, where key proposals were approved, including the election of directors and an amendment to the company's incentive plan. However, the transcript lacks specific financial results such as revenue and earnings for the quarter or fiscal year, leaving investors without critical performance metrics or guidance updates. The absence of financial data may lead to uncertainty regarding the company's current standing and future outlook.
Reported metrics
| Metric | Value |
|---|---|
| Revenue | |
| Earnings | |
| Director Votes | 11,630,133 (positive) |
| Incentive Plan Shares | 8,750,000 (positive) |
What analysts pressed on
Analysts expressed concerns regarding the lack of disclosed financial performance metrics during the meeting. The absence of revenue and earnings data raises questions about the company's current financial health and future growth prospects.
Main topics on the call
- Director Elections — The meeting confirmed the election of Bethoven and Kevin Weber as Class II directors, which is a standard governance practice. Management expressed satisfaction with the outcome, indicating stability in leadership.
- Incentive Plan Amendment — An amendment to the 2021 Omnibus incentive plan was approved, increasing the number of shares authorized for issuance by 5 million. This move signals management's intent to incentivize performance and retain key talent.
- Appointment of Auditors — The proposal to ratify CBS CPI PC as the independent registered public accounting firm for the fiscal year ending December 31, 2026, was approved. This reflects ongoing compliance with regulatory requirements.
Read the full Biofrontera Inc. transcript (June 11, 2026) → Summary generated from the call transcript; every figure above is stated by management on the record.
About Biofrontera Inc.
Biofrontera Inc. (BFRI) is a publicly listed company in the Pharmaceuticals industry, within the Health Care sector. It trades on NasdaqCM and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 16 calls on record spanning November 14, 2022 to June 11, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.
Earnings Call History
EarningsCalls.dev has 16 Biofrontera Inc. earnings call transcripts on record, spanning November 14, 2022 to June 11, 2026. Based on this history, Biofrontera Inc. reports quarterly. The most recent call on file is dated June 11, 2026. The full list is below — each row opens the complete, free-to-read transcript.
- Ticker
- BFRI
- Exchange
- NasdaqCM
- Country
- US
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Calls on record
- 16
- First call
- November 14, 2022
- Most recent
- June 11, 2026
- Reporting cadence
- quarterly
| Quarter | Date | |
|---|---|---|
| Shareholder/Analyst Calls | Jun 11, 2026 | Read transcript → |
| Q1 FY2026 | May 14, 2026 | Read transcript → |
| Q4 FY2025 | Mar 19, 2026 | Read transcript → |
| Q3 FY2025 | Nov 13, 2025 | Read transcript → |
| Q2 FY2025 | Aug 14, 2025 | Read transcript → |
| Q1 FY2025 | May 16, 2025 | Read transcript → |
| Q4 FY2024 | Mar 21, 2025 | Read transcript → |
| Earnings Calls | Nov 14, 2024 | Read transcript → |
| Q2 FY2024 | Aug 15, 2024 | Read transcript → |
| Q1 FY2024 | May 16, 2024 | Read transcript → |
| Q4 FY2023 | Mar 18, 2024 | Read transcript → |
| Q3 FY2023 | Nov 10, 2023 | Read transcript → |
| Q2 FY2023 | Aug 11, 2023 | Read transcript → |
| Q1 FY2023 | May 12, 2023 | Read transcript → |
| Q4 FY2022 | Mar 8, 2023 | Read transcript → |
| Earnings Calls | Nov 14, 2022 | Read transcript → |